IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. — Investor Relations & Filings
IMEIK Technology Development Co., Ltd. focuses on the research, development, and commercialization of biomedical materials, specifically targeting the aesthetic medicine sector. The company’s primary product line consists of injectable hyaluronic acid fillers and facial implants designed for soft tissue repair and augmentation. Utilizing proprietary cross-linking technologies, the firm produces high-purity formulations such as Hi-Tech and Hearty. Its portfolio also encompasses skin repair products and solutions for minimally invasive procedures. The organization prioritizes technological innovation and maintains a robust pipeline of Class III medical device registrations. By leveraging advanced biotechnology, the company provides clinical-grade materials to medical institutions and specialized clinics, emphasizing safety, efficacy, and biocompatibility in its product offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第三届监事会第三次会议决议公告 | 2023-03-31 | Chinese | |
| 2023年第一期限制性股票激励计划首次授予激励对象名单（首次授予日） | 2023-03-31 | Chinese | |
| 关于向2023年第一期限制性股票激励计划激励对象首次授予限制性股票的公告 | 2023-03-31 | Chinese | |
| 北京海润天睿律师事务所关于爱美客技术发展股份有限公司向2023年第一期限制性股票激励计划激励对象首次授予限制性股票相关事项的法律意见书 | 2023-03-31 | Chinese | |
| 监事会关于2023年第一期限制性股票激励计划首次授予日激励对象人员名单的核实意见 | 2023-03-31 | Chinese | |
| 关于2023年第一期限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 | 2023-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 38854158 | 第三届监事会第三次会议决议公告 | 2023-03-31 | Chinese | ||
| 38854145 | 2023年第一期限制性股票激励计划首次授予激励对象名单（首次授予日） | 2023-03-31 | Chinese | ||
| 38854135 | 关于向2023年第一期限制性股票激励计划激励对象首次授予限制性股票的公告 | 2023-03-31 | Chinese | ||
| 38854128 | 北京海润天睿律师事务所关于爱美客技术发展股份有限公司向2023年第一期限制性股票激励计划激励对象首次授予限制性股票相关事项的法律意见书 | 2023-03-31 | Chinese | ||
| 38854116 | 监事会关于2023年第一期限制性股票激励计划首次授予日激励对象人员名单的核实意见 | 2023-03-31 | Chinese | ||
| 38854105 | 关于2023年第一期限制性股票激励计划内幕信息知情人买卖公司股票情况的自查报告 | 2023-03-30 | Chinese | ||
| 38854096 | 2022年度股东大会决议公告 | 2023-03-30 | Chinese | ||
| 38854087 | 北京海润天睿律师事务所关于爱美客技术发展股份有限公司2022 年度股东大会的法律意见 | 2023-03-30 | Chinese | ||
| 38854074 | 监事会关于2023年第一期限制性股票激励计划激励对象名单的核查意见及公示情况说明 | 2023-03-23 | Chinese | ||
| 38854064 | 中信证券股份有限公司关于爱美客技术发展股份有限公司2022年度持续督导跟踪报告 | 2023-03-15 | Chinese | ||
| 38854050 | 创业板上市公司股权激励计划自查表 | 2023-03-08 | Chinese | ||
| 38854037 | 董事会关于证券投资情况的专项说明 | 2023-03-08 | Chinese | ||
| 38854024 | 董事会决议公告 | 2023-03-08 | Chinese | ||
| 38854010 | 年度募集资金存放与使用情况鉴证报告 | 2023-03-08 | Chinese | ||
| 38853984 | 公司章程 | 2023-03-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55863/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55863 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55863 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55863 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55863}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. (id: 55863)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.